Vincent Breet

Vincent is an experienced life sciences consultant who utilizes his background in science, engineering, and business to aid clients in turning blue ocean ideas into data-driven, actionable insights and strategies to drive market-shaping innovation.

He possesses a strong background in early-stage and new product launch strategy across the pharmaceutical industry, ranging from pre-launch strategic pricing assessments, launch strategy playbooks, conducting due diligence on pending acquisitions, to evaluating clinical feasibility of a therapeutic organ transplantation technique in novel disease areas. Vincent’s experience spans all settings of care and multiple therapeutic areas, with specific expertise in hematology-oncology and rare disease.

Throughout his career, Vincent has supported clients ranging from Series B-funded biotechs to Top 5 Pharma, helping them deliver on the commitment to optimize patient and provider outcomes while also maximizing commercial results. Clients appreciate his immediate grasp of key issues and rigorous approach to problem-solving.